Lifestyle
- Regular physical exercise
- Weight management
- Smoking cessation
Adiponectin · APN · GBP-28
Adiponectin quantifies the concentration of an adipokine involved in glucose regulation and fatty acid oxidation.
Levels can vary based on sex, body composition, and lifestyle factors.
Adiponectin, also known as APN or GBP-28, is an adipokine predominantly secreted by adipocytes. It plays a crucial role in regulating glucose levels and fatty acid breakdown. Biologically, adiponectin is involved in enhancing insulin sensitivity and possesses anti-inflammatory and anti-atherogenic properties. Researchers have found that adiponectin levels are inversely correlated with body fat percentage, particularly visceral fat, and are influenced by factors such as genetic polymorphisms, diet, and physical activity. Clinically, adiponectin is significant as it is associated with various metabolic disorders including type 2 diabetes, metabolic syndrome, and cardiovascular diseases. Elevated levels of adiponectin are linked to reduced risk of atherosclerosis and improved insulin sensitivity, whereas low levels are associated with increased risk of obesity-related conditions. For athletes and biohackers, adiponectin is of interest due to its role in energy metabolism and potential implications for enhancing insulin sensitivity and reducing inflammation, which could contribute to improved performance and recovery. However, researchers observed that adiponectin's relationship with bone density and its paradoxical association with body weight present challenges. Confounding factors such as sleep deprivation, smoking, and medication use can affect adiponectin levels, and fasting status may also influence measurements. Time-of-day variations have not been extensively documented, but consistent testing conditions are recommended for accurate assessment.
Klinische Bedeutung
Low adiponectin levels suggest increased risk for metabolic disorders such as type 2 diabetes and cardiovascular diseases. High levels are generally protective but may be associated with certain conditions like cardiac and renal diseases.
Increasing adiponectin levels may indicate improved insulin sensitivity and reduced inflammation. Re-test in 6 months if levels are significantly elevated.
Decreasing levels could suggest worsening metabolic health or increased risk of obesity-related conditions.
Re-test Interval
6 months if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle changes.
Adiponectin levels can vary throughout the day; morning fasting samples are recommended for consistency.
Testing Frequency
Annually for individuals with metabolic risk factors.
Correlated with
Current research suggests that the relationship between adiponectin levels and various cardiometabolic diseases remains debated, particularly regarding reference ranges and the influence of confounders such as obesity and lifestyle factors. Researchers have not yet established optimal targets for adiponectin in clinical practice, and emerging research directions include its potential role in cancer prevention and bone metabolism. Unanswered clinical questions include the mechanisms underlying adiponectin's protective effects and its variability in different populations.
1,593
Total Citations
3
Human/RCT
6.3
Avg. Influence
2025
Latest
Turer A T & Scherer P E · Diabetologia · 2012
This review highlighted the various functions of adiponectin and its role as a biomarker. Researchers found that adiponectin is associated with positive metabolic effects and is linked to insulin sensitivity and cardiovascular health. The review summarizes key epidemiological data supporting adiponectin's role as a robust clinical biomarker.
Key findings
Khoramipour Kayvan, et al. · Nutrients · 2021
This review explored the structure and functions of adiponectin, a protein secreted by fat tissues. Researchers found that adiponectin plays a role in various physiological processes and is negatively correlated with diseases like cancer and diabetes. The review suggests that adiponectin could serve as a biomarker for diagnosing these conditions.
Key findings
This review discussed the multifaceted role of adiponectin in relation to obesity and cardiovascular diseases. Researchers found that adiponectin has anti-inflammatory and insulin-sensitizing properties, and its levels are influenced by various factors including diet and exercise. The review highlights the potential of adiponectin as a prognostic biomarker and therapeutic target in cardiometabolic diseases.
Kishida Ken, et al. · Best practice & research. Clinical endocrinology & metabolism · 2014
This review article emphasized the significance of adiponectin as a clinical biomarker for obesity-related diseases. Researchers found that low levels of adiponectin are linked to various health issues, including type 2 diabetes and cardiovascular diseases. The review recommends routine measurement of adiponectin in patients with lifestyle-related diseases.
Key findings
This study examined the effects of acute sleep deprivation on blood levels of leptin, ghrelin, and adiponectin in adults. Researchers found that after one night of sleep loss, levels of adiponectin increased significantly, particularly among normal-weight participants, while leptin levels decreased. The findings suggest that these hormonal changes may contribute to weight gain if sleep deprivation persists.
This study investigated the relationship between adiponectin levels and bone health. Researchers found that lower adiponectin levels are associated with higher fat mass and negatively correlate with bone mineral density. The findings suggest that adiponectin may play a complex role in bone metabolism, warranting further research.
This review addressed the roles of leptin and adiponectin in ischemic stroke. Researchers found that these adipocytokines are linked to inflammation and atherosclerosis. The study suggests that measuring their levels may serve as a novel prognostic biomarker for stroke.
Dalamaga Maria & Christodoulatos Gerasimos S · Hormone molecular biology and clinical investigation · 2015
This review discussed the link between adiponectin and hematologic malignancies. Researchers found that low adiponectin levels are associated with an increased risk of certain cancers. The study suggests that adiponectin may serve as a biomarker for cancer progression in overweight individuals.
Key findings
Peng Jin, et al. · Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology · 2023
This review explored the role of adiponectin in cardiovascular disease (CVD). Researchers found that adiponectin has protective effects against CVD by improving lipid metabolism and endothelial function. The review suggests that adiponectin could be a valuable therapeutic target and biomarker for diagnosing and treating CVD.
Key findings
This review examined the role of adiponectin in preeclampsia. Researchers found that adiponectin levels change during pregnancy and are linked to the disease's symptoms. The study suggests adiponectin could be a promising biomarker and therapeutic target for managing preeclampsia.
Research publications about Adiponektin over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer